辅助人工心臟市场报告：2030 年趋势、预测与竞争分析

辅助人工心臟的趋势与预测

预计到 2030 年，全球辅助人工心臟市场将达到 32 亿美元，2024 年至 2030 年复合年增长率为 10.5%。该市场的关键驱动因素是心臟衰竭盛行率的上升和心血管疾病患者数量的增加。全球辅助人工心臟市场的未来看起来充满希望，在桥接移植、目的地治疗、桥接恢復和桥接治疗应用方面存在机会。

辅助人工心臟市场洞察

Lucintel 预测，由于心臟病患者越来越多地使用植入式心室辅助人工心臟将出现更高的增长。

在这个市场中，目的地治疗预计将经历最高的成长。

由于该地区拥有强大的医疗保健系统和主要企业，预计北美地区将在预测期内实现最高的成长。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球辅助人工心臟市场预计将达到 32 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球辅助人工心臟市场预计将以10.5%的复合年增长率成长。

Q3.影响市场成长的关键驱动因素是：

A3. 该市场的关键驱动因素是心臟衰竭盛行率的上升和心血管疾病患者数量的增加。

Q4.市场的主要细分市场是：

A4.辅助人工心臟市场的未来看起来很有希望，在移植桥、目的地治疗、恢復桥和治疗桥应用方面都有机会。

Q5.市场的主要企业是：

A5. 主要的辅助人工心臟公司如下。

• Abbott Laboratories
• Corewave
• Bivacor
• Carmat
• Jarvik Heart

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于心臟病患者越来越多地使用植入式心室辅助人工心臟预计将出现更高的增长。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于该地区拥有强大的医疗保健系统和主要企业，预计北美地区将在预测期内实现最高的增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 列出了 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球辅助人工心臟市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球辅助人工心臟市场趋势（2018-2023）与预测（2024-2030）
• 全球辅助人工心臟市场的设计
  • 经皮心室辅助装置
  • 植入式辅助人工心臟
• 按产品分類的全球辅助人工心臟市场
  • 左心室辅助装置 (LVAD)
  • 右心室辅助装置 (RVAD)
  • 双心室辅助装置（BIVAD）
• 全球辅助人工心臟市场（按应用）
  • 移植的桥樑
  • 目的地治疗
  • 恢復的桥樑
  • 通往候选疗法的桥樑
• 全球辅助人工心臟市场（依最终用途）
  • 门诊手术中心
  • 医院
  • 其他的

第四章 2018-2030年分地区市场趋势及预测分析

• 全球辅助人工心臟市场（按地区）
• 北美辅助人工心臟市场
• 欧洲辅助人工心臟市场
• 亚太心室辅助人工心臟市场
• 其他地区辅助人工心臟市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球辅助人工心臟市场设计成长机会
  • 全球辅助人工心臟市场成长机会（按产品）
  • 全球辅助人工心臟市场成长机会（按应用）
  • 全球辅助人工心臟市场成长机会（依最终用途）
  • 全球辅助人工心臟市场成长机会（按地区）
• 全球辅助人工心臟市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球辅助人工心臟市场的产能
  • 全球辅助人工心臟市场的合併、收购与合资企业
  • 认证和许可

第七章主要企业概况

• Abbott Laboratories
• Corewave
• Bivacor
• Carmat
• Jarvik Heart

Ventricular Assist Device Trends and Forecast

The future of the global ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications. The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.

A more than 150-page report is developed to help in your business decisions.

Ventricular Assist Device by Segment

The study includes a forecast for the global ventricular assist device by design, product, application, end use, and region.

Ventricular Assist Device Market by Design [Shipment Analysis by Value from 2018 to 2030]:

• Transcutaneous Ventricular Assist Devices
• Implantable Ventricular Assist Devices

Ventricular Assist Device Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Left Ventricular Assist Devices (LVADs)
• Right Ventricular Assist Devices (RVADs)
• Biventricular Assist Devices (BIVADs)

Ventricular Assist Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Bridge-to-Transplant
• Destination Therapy
• Bridge-to-Recovery
• Bridge to Candidacy Therapy

Ventricular Assist Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Ambulatory Surgery Centers
• Hospital
• Others

Ventricular Assist Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Ventricular Assist Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ventricular assist device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ventricular assist device companies profiled in this report include-

• Abbott Laboratories
• Corewave
• Bivacor
• Carmat
• Jarvik Heart

Ventricular Assist Device Market Insights

Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.

Within this market, destination therapy is expected to witness the highest growth.

North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.

Features of the Global Ventricular Assist Device Market

Market Size Estimates: Ventricular assist device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ventricular assist device market size by various segments, such as by design, product, application, end use, and region in terms of value ($B).

Regional Analysis: Ventricular assist device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different designs, products, applications, end uses, and regions for the ventricular assist device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ventricular assist device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the ventricular assist device market size?

Answer: The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030.

Q2. What is the growth forecast for ventricular assist device market?

Answer: The global ventricular assist device market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the ventricular assist device market?

Answer: The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.

Q4. What are the major segments for ventricular assist device market?

Answer: The future of the ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications.

Q5. Who are the key ventricular assist device market companies?

Answer: Some of the key ventricular assist device companies are as follows:

• Abbott Laboratories
• Corewave
• Bivacor
• Carmat
• Jarvik Heart

Q6. Which ventricular assist device market segment will be the largest in future?

Answer: Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.

Q7. In ventricular assist device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the ventricular assist device market by design (transcutaneous ventricular assist devices and implantable ventricular assist devices), product (left ventricular assist devices, right ventricular assist devices, and biventricular assist devices), application (bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy), end use (ambulatory surgery centers, hospital, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ventricular Assist Device Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Ventricular Assist Device Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Ventricular Assist Device Market by Design
  • 3.3.1: Transcutaneous Ventricular Assist Devices
  • 3.3.2: Implantable Ventricular Assist Devices
• 3.4: Global Ventricular Assist Device Market by Product
  • 3.4.1: Left Ventricular Assist Devices (LVADs)
  • 3.4.2: Right Ventricular Assist Devices (RVADs)
  • 3.4.3: Biventricular Assist Devices (BIVADs)
• 3.5: Global Ventricular Assist Device Market by Application
  • 3.5.1: Bridge-to-Transplant
  • 3.5.2: Destination Therapy
  • 3.5.3: Bridge-to-Recovery
  • 3.5.4: Bridge to Candidacy Therapy
• 3.6: Global Ventricular Assist Device Market by End Use
  • 3.6.1: Ambulatory Surgery Centers
  • 3.6.2: Hospital
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Ventricular Assist Device Market by Region
• 4.2: North American Ventricular Assist Device Market
  • 4.2.2: North American Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
• 4.3: European Ventricular Assist Device Market
  • 4.3.1: European Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
  • 4.3.2: European Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
• 4.4: APAC Ventricular Assist Device Market
  • 4.4.1: APAC Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
  • 4.4.2: APAC Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
• 4.5: ROW Ventricular Assist Device Market
  • 4.5.1: ROW Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
  • 4.5.2: ROW Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Ventricular Assist Device Market by Design
  • 6.1.2: Growth Opportunities for the Global Ventricular Assist Device Market by Product
  • 6.1.3: Growth Opportunities for the Global Ventricular Assist Device Market by Application
  • 6.1.4: Growth Opportunities for the Global Ventricular Assist Device Market by End Use
  • 6.1.5: Growth Opportunities for the Global Ventricular Assist Device Market by Region
• 6.2: Emerging Trends in the Global Ventricular Assist Device Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Ventricular Assist Device Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ventricular Assist Device Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott Laboratories
• 7.2: Corewave
• 7.3: Bivacor
• 7.4: Carmat
• 7.5: Jarvik Heart